Contrive Datum Insights has published "Medical Devices Market Size, Share & Industry Analysis, By Type (Cardiovascular Devices, Diagnostic Imaging, IVD, Orthopedic Devices, MIS, Wound Management, Diabetes Care, Ophthalmic, Dental, Nephrology, General Surgery, Others), End-user (Hospitals & ASCs, Clinics, Others), Application (Diagnostic, Therapeutic, Monitoring & Management, Surgical, Others), Distribution channel (Direct Tenders & Institutional Sales, Third-Party Distributors, Retail Pharmacies & Medical Stores, Online/E-commerce), Device class (Class I, Class II, Class III), and Regional Forecast, 2026-2034". The study sizes the global medical devices market at USD 665 billion in 2025 and projects growth from USD 700 billion in 2026 to USD 1177 billion by 2034, a compound annual growth rate of 6.72% across the forecast period.
Medical devices are instruments, apparatus, implants, and in vitro reagents used to diagnose, monitor, or treat a medical condition, ranging from single-use consumables and diagnostic test kits to capital equipment such as imaging systems and surgical robotics. Buyers include hospitals and ambulatory surgical centers, independent diagnostic and clinical laboratories, physician clinics, and, for a growing share of monitoring and self-testing products, patients and caregivers purchasing directly or through pharmacies. Purchasing decisions typically involve clinical, procurement, and biomedical engineering staff jointly, reflecting both patient-outcome requirements and total cost of ownership over a device's service life.
Rising chronic disease burden and expanding treatment eligibility
Rising chronic disease burden and expanding treatment eligibility is the largest single contributor to the market's growth over the forecast period, and the study rates its impact high. Against a market growing at 6.72% a year, the type lines exposed to it move fastest: MIS compounds at 8.64%, taking its share of revenue from 8.5% to 10% and its value from USD 56.53 billion to USD 117.7 billion.
On the upside, the study's bull case assumes reimbursement expansion and faster device approvals in Asia Pacific pull category adoption forward across cardiovascular, diagnostic imaging and in-vitro diagnostics, which would take 2034 revenue to USD 1259.39 billion against the USD 1177 billion base case.
On the downside, tighter reimbursement and price controls in major markets slow capital equipment replacement cycles and delay approvals for newer device categories, which would hold 2034 revenue to USD 1094.61 billion. Cardiovascular Devices, which carries 15% of 2025 revenue, already grows at only 6.31% against the market's 6.72%, so the largest part of the base is also its slowest.
Key Players Compete on Cardiovascular Devices Volume and MIS Growth
Suppliers here are separated by type, not by geography. The incumbent position is Cardiovascular Devices: 15% of 2025 revenue, USD 99.75 billion, and still 14.5% in 2034. The contested position is MIS at 8.64% growth. Few suppliers hold both, which is why a market of USD 665 billion supports as many participants as it does.
Further Report Findings
| Segment | Led 2025 by | Share & value | Fastest-growing |
|---|---|---|---|
| End-user | Hospitals & ASCs | 62% · USD 412.3 billion | Clinics 7.85% |
| Application | Diagnostic | 32% · USD 212.8 billion | Monitoring & Management 7.8% |
| Distribution channel | Direct Tenders & Institutional Sales | 45% · USD 299.25 billion | Online/E-commerce 13.39% |
| Device class | Class II | 50% · USD 332.5 billion | Class III 7.9% |
- North America was the largest region in 2025, holding 40% of global revenue at USD 266 billion and reaching USD 423.72 billion by 2034.
- Asia Pacific takes a rising share of global revenue over the forecast period, from 26% in 2025 to 31% in 2034, with revenue growing from USD 172.9 billion to USD 364.87 billion.
- At 5% of 2025 revenue and 5% by 2034, Middle East and Africa is the smallest region throughout.
- By type, the largest line in 2025 was Cardiovascular Devices, at 15% of revenue and USD 99.75 billion.
- The fastest type line is MIS, forecast to compound at 8.64% through the period.
- The United States is the largest single country market at USD 223.44 billion in 2025, 33.6% of global revenue.
The study covers five axes, by type, and by end-user, application, distribution channel and device class, reporting revenue and a growth rate for every line in every year from 2020 to 2034, with bear, base and bull scenarios on the headline total at USD 1094.61 billion and USD 1259.39 billion by 2034. Country-level detail is given for all five regions, together with the competitive landscape and the research methodology. Delivered as a PDF; request a free sample to review it.